Use of spironolactone-based composition that exhibits an inhibitory action on T-lymphocyte activation wich is useful for preventing and/or treating multiple sclerosis exhibits an inhibitory action on T-Lymphocyte activation which is useful for preventing and/or treating multiple

dc.catalogadorjca
dc.contributor.authorKalergis Parra, Alexis Mikes
dc.contributor.authorHerrada Hidalgo, Andrés Alonso
dc.date.accessioned2021-06-14T17:48:19Z
dc.date.available2021-06-14T17:48:19Z
dc.date.concesion2017
dc.date.created2013
dc.descriptionPatente de invención
dc.estado.patenteCONCEDIDA
dc.fechaingreso.objetodigitalNo aplica
dc.fuente.origenPropiedad intelectual
dc.identifier.UAFacultad de Ciencias Biológicas
dc.identifier.concesion9,849,141
dc.identifier.govdoc14/104,799
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/60673
dc.language.isoen
dc.nota.accesoSin adjunto
dc.paisUSA
dc.presentacionExtranjera
dc.rightsregistro bibliográfico
dc.solicitantePontificia Universidad Católica de Chile
dc.subjectSalud
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.territorialidadExtranjera
dc.titleUse of spironolactone-based composition that exhibits an inhibitory action on T-lymphocyte activation wich is useful for preventing and/or treating multiple sclerosis exhibits an inhibitory action on T-Lymphocyte activation which is useful for preventing and/or treating multiplees_ES
dc.typepatente
sipa.codpersvinculados90610
sipa.codpersvinculados174374
Files